Biden Has Completed Radiation for Cancer
Digest more
Prostate cancer relies on genetic "switches," called enhancers, that can turn on tumor-promoting genes. Researchers at the University of Michigan Health Rogel Cancer Center have discovered histone H2B N-terminal acetylation (H2BNTac),
In a meeting Tuesday, the Prostate Cancer Study Committee heard the final recommendations on how to fight prostate cancer in South Carolina.
A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to results of a drug treatment trial in men whose prostate cancer had returned.